Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
197 Cards in this Set
- Front
- Back
|
ACEIs
Suffix |
ACEIs
-pril |
|
|
Alpha Blocker
Suffix |
Alpha Blocker
-azosin |
|
|
Anticoagulant
Suffix |
Anticoagulant
-parin |
|
|
ARBs
Suffix |
ARBS
-sartan |
|
|
Beta Blockers
Suffix |
Beta Blockers
-olol |
|
|
CCBs (DHPs)
Suffix |
CCBs (DHP)
-dipine |
|
|
HMG CoA Reductase inhibitors
Suffix |
HMG CoA Reductase Inhibitors (Statins)
-statin |
|
|
Loop Diuretic
Suffix |
Loop Diuretic
-semide |
|
|
Thiazide
Suffix |
Thiazide
-thiaside |
|
|
Thrombolytic
Suffix |
Thrombolytic
-ase, -plase |
|
|
Thiazide Diuretics
|
Hydrochlorothiazide
|
|
|
Hydrocholorthiazide
|
Thiazide Diuretics
|
|
|
Potassium-sparing diuretics
|
Triamterene, Amiloride, Spironolactone
|
|
|
Loop diuretics
|
Furosemide, Bumetanide, torsemide
|
|
|
Aldosterone Antagonists/ SARA
|
Eplerenone
|
|
|
Eplerenone
|
Aldosterone Antagonists/ SARA
|
|
|
Beta Blocker (Non-Selective)
|
Propranolol
|
|
|
Propranolol
|
Beta Blocker (Non-Selective), Class II
|
|
|
Beta-Blocker (Selective)
|
Atenolol, Metoprolol, Bisoprolol, Esmolol
|
|
|
Beta-Blocker (Partial)
|
Acebutolol, Carteolol, Penartolol, Pindolol
|
|
|
Mixed a1/B1/B2 Blocker
|
Labetalol, Carvedilol
|
|
|
Central Acting Agents/ a2 agonist
|
Methyldopa, Clonidine
|
|
|
Alpha Adrenoreceptor Antagonists/ a1 blocker
|
Doxazosin, Prazosin, Tamsulosin, Terazosin
|
|
|
Direct Renin Inhibitor
|
Aliskiren
|
|
|
Aliskiren
|
Direct Renin Inhibitor
|
|
|
ACE Inhibitor
|
Ramipril, Lisinopril, Captoprin, Enalapril, Fosinopril, quinapril, benazepril
|
|
|
Calcium Channel Blocker (Dihydropines)
|
Amlodipine, Felodipine, Nifedipine, Nicardipine, Nimodipine
|
|
|
Amlodipine, Felodipine, Nifedipine, Nicardipine, Nimodipine
|
Calcium Channel Blocker (Dihydropines)
|
|
|
Calcium Channel Blocker (Non-Dihydropines)
|
Verapamil, Diltiazem
|
|
|
ARB
|
Losarten, Valsarten, Olmesartan
|
|
|
Vasodilator
|
Hydralazine, Nitroprusside, Fenoldopam, Minoxidil
|
|
|
Nitrates
|
Glyceral Trinitrate, Isosorbide mononitrate, Isosoribide Dinitrate, Nitroglycerin
|
|
|
Triamterene
|
Potassium-sparing diuretics
|
|
|
Amiloride
|
Potassium-sparing diuretics
|
|
|
Spironolactone
|
Potassium-sparing diuretics
|
|
|
Furosemide
|
Loop diuretics
|
|
|
Bumetanide
|
Loop diuretics
|
|
|
torsemide
|
Loop diuretics
|
|
|
Atenolol
|
Beta-Blocker (Selective),Class II
|
|
|
Metoprolol
|
Beta-Blocker (Selective), Class II
|
|
|
Bisoprolol
|
Beta-Blocker (Selective), Class II
|
|
|
Esmolol
|
Beta-Blocker (Selective), Class II
|
|
|
Acebutolol
|
Beta-Blocker (Partial),Class II
|
|
|
Carteolol
|
Beta-Blocker (Partial), Class II
|
|
|
Penartolol
|
Beta-Blocker (Partial), Class II
|
|
|
Pindolol
|
Beta-Blocker (Partial), Class II
|
|
|
Labetalol
|
Mixed a1/B1/B2 Blocker, Class II
|
|
|
Carvedilol
|
Mixed a1/B1/B2 Blocker, Class II
|
|
|
Methyldopa
|
Central Acting Agents/ a2 agonist
|
|
|
Clonidine
|
Central Acting Agents/ a2 agonist
|
|
|
Doxazosin
|
Alpha Adrenoreceptor Antagonists/ a1 blocker
|
|
|
Prazosin
|
Alpha Adrenoreceptor Antagonists/ a1 blocker
|
|
|
Tamsulosin
|
Alpha Adrenoreceptor Antagonists/ a1 blocker
|
|
|
Terazosin
|
Alpha Adrenoreceptor Antagonists/ a1 blocker
|
|
|
Ramipril
|
ACE Inhibitor
|
|
|
Lisinopril
|
ACE Inhibitor
|
|
|
Captoprin
|
ACE Inhibitor
|
|
|
Enalapril
|
ACE Inhibitor
|
|
|
Fosinopril
|
ACE Inhibitor
|
|
|
quinapril
|
ACE Inhibitor
|
|
|
benazepril
|
ACE Inhibitor
|
|
|
Losarten
|
ARB
|
|
|
Valsarten
|
ARB
|
|
|
Olmesartan
|
ARB
|
|
|
Hydralazine
|
Vasodilator
|
|
|
Nitroprusside
|
Vasodilator
|
|
|
Fenoldopam
|
Vasodilator
|
|
|
Minoxidil
|
Vasodilator
|
|
|
Glyceral Trinitrate
|
Nitrates
|
|
|
Isosorbide mononitrate
|
Nitrates
|
|
|
Isosoribide Dinitrate
|
Nitrates
|
|
|
Nitroglycerin
|
Nitrates
|
|
|
Nitrate/Vasodilator
|
Bidil
|
|
|
Bidil
|
Nitrate/Vasodilator
|
|
|
Venodilator
|
Nitroglycerin
|
|
|
Nitroglycerin
|
Venodilators
|
|
|
Inotrope/Vasopressor
|
Dobutamine, Milrinone
|
|
|
Dobutamine
|
Inotrope/Vasopressor
|
|
|
Milrinone
|
Inotrope/Vasopressor
|
|
|
Natriuretic Peptide
|
Nesiritide
|
|
|
Nesiritide
|
Natriuretic Peptide
|
|
|
Class 1a
|
Quinidine, Disopyramide, Procainamide
|
|
|
Quinidine
|
Class 1a
|
|
|
Disopyramide
|
Class 1a
|
|
|
Procainamide
|
Class 1a
|
|
|
Class 1b
|
Lidocaine, Mexiletine
|
|
|
Lidocaine
|
Class 1b
|
|
|
Mexiletine
|
Class 1b
|
|
|
Class 1c
|
Flecainide, Propafenone, Morcizine
|
|
|
Flecainide
|
Class 1c
|
|
|
Propafenone
|
Class 1c
|
|
|
Morcizine
|
Class 1c
|
|
|
Class II
|
Betablockers
Propranolol, Atenolol, Metoprolol, Acebutolol, Bisoprolol, Nebivolol, Labetalol, Carvedilol, Pindolol |
|
|
Class III
|
Amiodarone, Sotalol, Ibutilide, Dofetilide
|
|
|
Amiodarone
|
Class III
|
|
|
Sotalol
|
Class III
|
|
|
Ibutilide
|
Class III
|
|
|
Dofetilide
|
Class III
|
|
|
Class IV
|
Verapamil, Diltiazem
|
|
|
Verapamil
|
Calcium Channel Blocker (Non-Dihydropines), Class IV
|
|
|
Diltiazem
|
Calcium Channel Blocker (Non-Dihydropines), Class IV
|
|
|
Cardiac Glycoside
|
Digoxin
|
|
|
Digoxin
|
Cardiac Glycoside
|
|
|
Antiplatelets/ADP Receptor Inhibitor/Thienopyrdinines
|
Ticlopidine, Clopidogrel, Prasugrel
|
|
|
Ticlopidine
|
Antiplatelets/ADP Receptor Inhibitor/Thienopyrdinines
|
|
|
Clopidogrel
|
Antiplatelets/ADP Receptor Inhibitor/Thienopyrdinines
|
|
|
Prasugrel
|
Antiplatelets/ADP Receptor Inhibitor/Thienopyrdinines
|
|
|
Phosphodiesterase Inhibitors/Antiplatelets/PDE5 Inhibitors
|
Dipyridamole
|
|
|
Dipyridamole
|
Phosphodiesterase Inhibitors/Antiplatelets/PDE5 Inhibitors
|
|
|
Anticoagulant
|
Warfarin, UFH, LMWH (enoxaparin)
|
|
|
Warfarin
|
Anticoagulant
|
|
|
UFH
|
Anticoagulant
|
|
|
LMWH (Enoxaparin)
|
Anticoagulant
|
|
|
Direct Thrombin Inhibitors
|
Dabigatran, Lepirudin, hirudin, desirudin, bivalirudin, Argatroban
|
|
|
Dabigatran
|
Direct Thrombin Inhibitors
|
|
|
Argatroban
|
Direct Thrombin Inhibitors
|
|
|
Salicylate/NSAID
|
Aspirin
|
|
|
Aspirin
|
Salicylate
|
|
|
Glycoprotein IIb/IIIa Inhibitor
|
Abciximab, Eptifibatide, Tirofiban
|
|
|
Abciximab
|
Glycoprotein IIb/IIIa Inhibitor
|
|
|
Eptifibatide
|
Glycoprotein IIb/IIIa Inhibitor
|
|
|
Tirofiban
|
Glycoprotein IIb/IIIa Inhibitor
|
|
|
Thrombolytic/tPA
|
Alteplase, tenecteplase, reteplase
|
|
|
Alteplase
|
Thrombolytic/tPA
|
|
|
tenecteplase
|
Thrombolytic/tPA
|
|
|
reteplase
|
Thrombolytic/tPA
|
|
|
Factor Xa Inhibitor
|
Fondaparinux
|
|
|
Fondaparinux
|
Factor Xa Inhibitor
|
|
|
Fibrinolytics
|
Streptokinase, Urokinase
|
|
|
Streptokinase
|
Fibrinolytics
|
|
|
Urokinase
|
Fibrinolytics
|
|
|
HMG CoA Reductase Inhibitors/Statins
|
Rosuvastatin, Atorvastatin, Simvastatin, Pravastatin, Lovastatin, Fluvastatin, Pitavastatin
|
|
|
Rosuvastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Atorvastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Simvastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Pravastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Lovastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Fluvastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Pitavastatin
|
HMG CoA Reductase Inhibitors/Statins
|
|
|
Bile Acid Sequestrants
|
Cholestyramine, Colesevelam, Colestipol
|
|
|
Cholestyramine
|
Bile Acid Sequestrants
|
|
|
Colesevelam
|
Bile Acid Sequestrants
|
|
|
Colestipol
|
Bile Acid Sequestrants
|
|
|
Cholesterol Absorption Inhibitors
|
Ezetimibe
|
|
|
Ezetimibe
|
Cholesterol Absorption Inhibitors
|
|
|
Fibrates
|
Gemfibrozil, Fenofibrate, Fenofibric acid
|
|
|
Gemfibrozil
|
Fibrates
|
|
|
Fenofibrate
|
Fibrates
|
|
|
Fenofibric acid
|
Fibrates
|
|
|
Niacins
|
Niacin
|
|
|
Diuretics
|
decrease renal Na+ reabsorption which reduces H2O reabsorption. Each class works in a different area of the nephron (secreted and concentrated into tubule reaching higher concentrations than in blood). Non-renal AE are low.
|
|
|
Beta-Blockers
|
antagonism of catecholamines at β-receptors (attenuation of cytotoxic and signalling effects of circulating catecholamines); Decreases cardiac output by decreasing HR and contractility = decrease CO; Initial compensatory increase in PVR; Decrease PR in long run by inhibition of β-receptors in kidney which decreases renin = decrease BP = decrease vasoconstriction and decrease Na+ & H2O retention; Produce resting bradycardia; Reduction in exercise-induced tachycardia; do not use in acute decompensated HF;BB Block SNS Response – important for DM and hypoglycemia!!!
|
|
|
ACE Inhibitors
|
Reverses vasoconstriction and volume retention that is caused by RAAS activation; reduces afterload which increase SV; increases GFR; increases natriuresis and diuresis; reversal of aldosterone-related volume retention decreases preload; statistically significant mortality benefit for HF
|
|
|
ARBs
|
Hemodynamic profile similar to ACEIs; lack of bradykinin-related vasodilation; mortality benefit – use when ACI is contraindicated, may be additive when used with ACEI; routine combination of ACEI, ARB and aldosterone antagonist not recommended
|
|
|
Vasodilators
|
initiates compensatory responses: tachycardia, activation of the renin-angiotensin-aldosterone system; give with β–blockers and diuretics; NO formation; K+ channel openers; D1 stimulation
|
|
|
Thiazide Diuretics - Uses
|
Hypertension Combined with loop for Heart Failure
|
|
|
Potassium-sparing diuretics - Uses
|
Secondary Hypertension, Severe heart Failure, Hypokalemia, Peripheral Edema
|
|
|
Loop Diuretics - Uses
|
Hypertension (but less effective than thiazides – used when renal impairment or resistant to multiple drug Tx), Heart Failure
|
|
|
Aldosterone Antagonists/ SARA - Uses
|
HF
|
|
|
Non-selective Beta-Blockers (B1 & B2 Blockers) - Uses
|
• Hypertension • Angina • Stable heart failure • Chronic CAD • 1st Degree AV Block • PVCs • PSVT • AFib/AFlutter
|
|
|
Selective Beta-Blockers (B1 Blockers) - Uses
|
• Hypertension • Angina • Stable heart failure • Chronic CAD • 1st Degree AV Block • PVCs • PSVT • AFib/AFlutter
|
|
|
Partial Beta-Blockers (B1 & B2 Blockers) - Uses
|
• Hypertension • Angina • Stable heart failure • Chronic CAD • 1st Degree AV Block • PVCs • PSVT • AFib/AFlutter
|
|
|
Mixed α1/B1/B2 Blockers - Uses
|
• HTN • HF
|
|
|
Central Acting Agents / α2 agonist - Uses
|
• HTN
|
|
|
Alpha-adrenoreceptor antagonists/ α 1- blockers - Uses
|
• HTN • BPH
|
|
|
Direct Renin Inhibitors - Uses
|
• HTN
|
|
|
ACE inhibitors - Uses
|
• Hypertension • Heart Failure • Post MI
|
|
|
Calcium Channel Blockers (Dihydropines) - Uses
|
• Hypertension • Angina • Supraventricular arrhythmia • Chronic CAD • 1st Degree AV Block
|
|
|
Calcium Channel Blockers (Non-dihydropines): - Uses
|
PSVT • AFib/AFlutter
|
|
|
Angiotensin II receptor antagonists/blockers/ARBs - Uses
|
• Hypertension • Alternative to ACE inhibitor in heart failure • HTN
|
|
|
Nitrates - Uses
|
• Prophylaxis and Treatment of angina. • LVF • Chronic CAD
|
|
|
Nitrate/Vasodilator - Uses
|
• HF
|
|
|
Venodilators - Uses
|
HF
|
|
|
Inotrope/Vasopressor - Uses
|
Used for short-term treatment of acute decompensated HF
|
|
|
Natriuretic Peptide - Uses
|
Short term treatment of acute decompensated HF
|
|
|
Class Ia - Uses
|
• Efficacy in suppressing ventricular arrhythmias has been shown to be poor leading to decreased use • May increase mortality despite suppressing cardiac arrhythmias
|
|
|
Class Ib - Uses
|
• Ventricular arrythm, especially VTach and VFib
|
|
|
Class Ic - Uses
|
• Ventricular arrhythmias • Only used for patients without structural heart disease
|
|
|
Class II - Uses
|
• Control ventricular rate in setting of AFib/AFlutter • Supraventricular tachycardias
|
|
|
Class III (K+ Channel) - Uses
|
• AFib, Aflutter, VFib
|
|
|
Class IV - Uses
|
• Control ventricular rate in the setting of AFIb/Aflutter • PSVT
|
|
|
Cardiac Glycoside - Uses
|
• AF • Atrial Flutter
|
|
|
Antiplatelets/Thienopyridines /ADP Receptor Inhibitors - Uses
|
• Anti-platelet • Unstable Angina • NSTEMI
|
|
|
Phosphodiesterase Inhibitors / Antiplatelets - Uses
|
• Prophylaxis against thromboembolic disorders • Alternative to exercise in thallium myocardial perfusion imaging
|
|
|
Anticoagulant - Uses
|
• Prophylaxis+treatment DVT, PE • Prophylaxis of embolization in AF, Rheumatic disease + prosthetic valves. • Treatment of DVT, PE. Prophylaxis of DVT/PE post op. • NSTEMI • Unstable Angina • PCI
|
|
|
Direct Thrombin Inhibitors - Uses
|
• For HIT to prevent further reduction of platelet count while preventing thrombosis
|
|
|
Salicylate - Uses
|
• Prevention and treatment of MI and stroke.
|
|
|
Glycoprotein IIb/IIIa Inhibitor - Uses
|
• Anti-platelet • Unstable Angina • NSTEMI
|
|
|
tPA (tissue Plasminogen Activator)/Thrombolytic - Uses
|
• STEMI • Ischemic Stroke • Massive PE • Central IV line occulsion
|
|
|
Factor Xa Inhibitor - Uses
|
• Blood Clot Prevention
|
|
|
Fibrinolytics - Uses
|
• Thrombolysis – Acute MI, stroke, PE
|
|
|
HMG CoA Reductase Inhibitors/Statins - Uses
|
• Prevention of cardiovascular disease
|
|
|
Bile Acid Sequestrants - Uses
|
• Cholesterol
|
|
|
Cholesterol Absorption Inhibitors - Uses
|
• Cholesterol
|
|
|
Fibrates - Uses
|
• Cholesterol
|
|
|
Niacins - Uses
|
• Cholesterol
|
|
|
Omega 3s - Uses
|
• Cholesterol
|
